Form 4: Molina Healthcare Director Acquires Shares

Molina Healthcare director Leo P. Grohowski acquired 317 shares of common stock as part of an equity incentive plan.

Summary

• Leo P. Grohowski, a Director of Molina Healthcare, Inc. (MOH), acquired 317 shares of common stock.
• The transaction occurred on January 1, 2026, as a grant under the Issuer's 2025 Equity Incentive Plan.
• The shares were granted in connection with Grohowski's services as a Director.
• The aggregate dollar value of the annual equity award to each director is $220,000, with $55,000 granted quarterly.
• The number of shares (317) was calculated based on the closing price of Molina Healthcare's common stock on December 31, 2025, which was $173.54, as January 1, 2026, was a non-trading day.
• Following this transaction, Leo P. Grohowski beneficially owns 900 shares of Molina Healthcare common stock directly.

Sentiment

Score: 6

Explanation: The filing reports a routine, expected equity grant to a director, which is a neutral event but slightly positive as it aligns director and shareholder interests. It does not contain any unexpected positive or negative news.

Positives

• A director's acquisition of shares, even through a grant, aligns their interests with those of shareholders, potentially indicating confidence in the company's future performance.
• The existence of an equity incentive plan for directors demonstrates a structured approach to compensation that encourages long-term commitment and performance.

Future Outlook

The filing indicates a continuation of the Issuer's 2025 Equity Incentive Plan, with quarterly grants to directors based on the closing price of the common stock on the first day of each quarter.

Management Comments

• The grant of stock was made under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.
• The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day.

Industry Context

Equity compensation for directors is a standard practice across many industries, including healthcare, to align the interests of board members with those of shareholders. This grant is consistent with typical corporate governance practices for publicly traded companies.

Comparison to Industry Standards

• The practice of granting equity awards to non-employee directors, such as Leo P. Grohowski, is a common compensation strategy in the healthcare sector and broader public markets.
• Many companies, including peers in the managed care space, utilize similar equity incentive plans to attract and retain qualified board members and to foster a long-term perspective on company performance.
• The quarterly vesting or granting schedule is also a standard approach, providing ongoing incentives rather than a single annual award.

Corporate Governance

Related Party Transactions

• The grant of 317 shares of common stock to Director Leo P. Grohowski under the Issuer's 2025 Equity Incentive Plan constitutes a related party transaction, as it involves compensation to a member of the company's board of directors.

Stakeholder Impact

• Shareholders: The equity grant aligns the director's financial interests with those of shareholders, potentially fostering decisions that enhance long-term shareholder value.
• Employees: No direct impact on employees is indicated by this specific filing, though equity incentive plans are a broader component of corporate compensation strategy.

Next Steps

• Future quarterly grants to directors are expected under the 2025 Equity Incentive Plan, with the next grant anticipated on the first day of the subsequent quarter.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-scheduled equity grant to a director as part of their compensation package. It does not provide new fundamental information about the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The transaction is an expected part of corporate governance and compensation practices.

Keywords

Molina Healthcare, MOH, Form 4, Insider Transaction, Stock Grant, Director Compensation, Equity Incentive Plan, Beneficial Ownership